Mahamaya Lifesciences Limited, a active public limited company, was established on 07 May 2002 in New Delhi, Delhi, India. Engaging in crop protection within the manufacturing sector, it holds CIN: U24233DL2002PTC115261. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹17.77 Cr.
Formerly known as Mahamaya Life Sciences Private Limited, Mahamaya Lifesciences Limited. It upholds a compliant status. Employing 40 professional, Its leadership includes Charudatta Digambar Mayee (Director), Sekhar Kavasseri Rajagopalan (Director), Lalitha Krishnamurthy (Whole-Time Director). Past directors included Charudatta Digambar Mayee, Sekhar Kavasseri Rajagopalan, Lalitha Krishnamurthy. It holds ₹86.22 Cr open charges and ₹61.23 Cr settled loans. Its latest AGM occurred on 20 July 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No:Dpt-033, Ground Floor, Plot No. 79-80 Dlf Prime Tower, F-Block, Okhla Phase-I, New Delhi, Delhi, 110020.
U24233DL2002PLC115261
115261
07 May 2002
₹25.00 Cr
₹17.77 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Mahamaya Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Charudatta Digambar Mayee | Director | 11 Dec 2024 | Current |
| Sekhar Kavasseri Rajagopalan | Director | 11 Dec 2024 | Current |
| Lalitha Krishnamurthy | Whole-Time Director | 07 May 2002 | Current |
| Gopal Krishna Raju | Director | 11 Dec 2024 | Current |
| Krishnamurthy Ganesan | Managing Director | 07 May 2002 | Current |
| Prashant Krishnamurthy | Director | 25 Aug 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 26 Dec 2024 | Past |
| Pramod Abcsdd | Director | 06 Jun 2024 | Past |
| Pramod Abcsdd | Additional Director | 26 Dec 2024 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mahamaya Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.18% increase. The company also saw a substantial improvement in profitability, with a 33% increase in profit. The company's net worth Soared by an impressive increase of 23.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mahamaya Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹862,156,500.00
₹612,317,761.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2024 | Axis Bank Limited | ₹1.15 Cr | Open |
| 24 Dec 2024 | Axis Bank Limited | ₹6.20 M | Open |
| 16 Apr 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹1.40 M | Open |
| 11 Mar 2024 | Others | ₹25.00 Cr | Open |
| 24 Jan 2024 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Mahamaya Lifesciences has a workforce of 40 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mahamaya Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahamaya Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 25.00 Cr registered on 11 Mar 2024 with Charge ID 100891147 was modified on 26 Sep 2025. was recorded as a recent event.
The activity A charge with Others of Rs. 5.00 Cr registered on 24 Jan 2024 with Charge ID 100859429 was modified on 29 May 2025. was completed.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 0.14 Cr registered on 16 Apr 2024 with Charge ID 100901491 was modified on 31 Jan 2025. was documented.
A charge registered on 20 Oct 2022 via Charge ID 100684517 with Hdfc Bank Limited was fully satisfied on 17 Jan 2025. was recorded as a recent event.
A charge registered on 24 Jun 2022 via Charge ID 100591513 with Hdfc Bank Limited was fully satisfied on 17 Jan 2025. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 1.15 Cr with Charge ID 101034346 was registered on 24 Dec 2024. was recorded as a recent event.
The CIN of Mahamaya Lifesciences Limited is U24233DL2002PLC115261.
Mahamaya Lifesciences Limited is headquartered at Unit No:Dpt-033, Ground Floor, Plot No. 79-80 Dlf Prime Tower, F-Block, Okhla Phase-I, New Delhi, Delhi, 110020.
Mahamaya Lifesciences Limited was incorporated on 07 May 2002.
The current directors of Mahamaya Lifesciences Limited are
The primary industry of Mahamaya Lifesciences Limited is Manufacturing.
Mahamaya Lifesciences Limited is unlisted.
The authorized capital of Mahamaya Lifesciences Limited is ₹25.00 Cr, and the paid-up capital is ₹17.77 Cr.
The compliance status of Mahamaya Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX